test

Flynn Management LLC, its general partner

@Deerfield Management Company, L.p. (series C)

Latest period2024 - Q3ReportedManaged Assets$6.693BTotal holdings443
Assets growth rate11.36%Assets growth rate (2-Q avg)7.96%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Deerfield Management Company, L.p. (series C)'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 443 positions.

Assets under management

The assets under management (AUM) of Deerfield Management Company, L.p. (series C) over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.693B in assets, with a quarterly growth rate of 11.36% and a 2-quarter average growth rate of 7.96%. The portfolio is managed by Flynn Management LLC, its general partner, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RVMDRevolution Medicines Inc
Recent Activity
Decreased -5.74%
1.98%
$132.091M
2.913M shares@ $45.35 avg price
ALHCAlignment Healthcare Inc
Recent Activity
Decreased -0.42%
1.92%
$128.306M
10.855M shares@ $11.83 avg price
CPRXCatalyst Pharmaceuticals Inc
Recent Activity
Decreased -31.74%
1.86%
$123.845M
6.23M shares@ $19.89 avg price
0043⤦Accolade Inc
Recent Activity
1.83%
$122.034M
132.598M shares@ $0.93 avg price
0204⤦Alnylam Pharmaceuticals Inc
Recent Activity
New Position
1.75%
$117.092M
100M shares@ $1.18 avg price
AHCOAdapthealth Corp
Recent Activity
Decreased -26.75%
1.63%
$109.059M
9.711M shares@ $11.23 avg price
BKDBrookdale Sr Living Inc
Recent Activity
1.59%
$106.007M
15.612M shares@ $6.8 avg price
KURAKura Oncology Inc
Recent Activity
1.58%
$105.742M
5.412M shares@ $19.54 avg price
0208⤦Alphatec Hldgs Inc
Recent Activity
New Position
1.58%
$105.718M
117.5M shares@ $0.9 avg price
6047⤦Mirum Pharmaceuticals Inc
Recent Activity
1.54%
$103.04M
70M shares@ $1.48 avg price